started · updated
Cancer diagnostics and breast cancer drug markets projected to grow through 2030
The global cancer diagnostics and treatment markets are poised for significant growth driven by technological innovation and rising clinical demand. The cancer diagnostics market is projected to grow from $28.58 billion in 2026 to $44.69 billion by 2030, representing a compound annual growth rate (CAGR) of 11.8%. Key drivers include advancements in artificial intelligence (AI) for oncology, next-generation sequencing, and molecular diagnostics.
Simultaneously, the breast cancer drugs market is expected to reach $61.19 billion by 2030, with a projected CAGR of 7.8%. This growth is fueled by the rising incidence of breast cancer, advancements in precision medicine, and innovations in biopharmaceuticals, including targeted therapies and hormone treatments.
Increased healthcare spending is also supporting these markets. For instance, data from the UK's Office for National Statistics indicated a 5.6% increase in total healthcare expenditure in 2023. In the United States, breast cancer continues to be a major health concern, accounting for approximately 30% of all new cancer cases among women.
Entities
BreastCancer.org · Office for National Statistics · The Business Research Company
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 2 SOURCES] AI-driven oncology diagnostics and next-generation sequencing are key drivers for the cancer diagnostics market.
- [● 2 SOURCES] The cancer diagnostics market is expected to grow at a CAGR of 11.8% between 2026 and 2030.
- [○ 1 SOURCE] Breast cancer accounts for approximately 30% of new cancer cases among women in the United States.
- [● 2 SOURCES] UK total healthcare expenditure in 2023 increased by 5.6% in nominal terms compared to 2022.
- [○ 1 SOURCE] The breast cancer drugs market is projected to reach $61.19 billion by 2030, with a CAGR of 7.8%.
- [○ 1 SOURCE] Breast cancer accounts for approximately 30% of all new cancer cases among women in the United States.
- [● 2 SOURCES] UK total healthcare expenditure increased by 5.6% in 2023 compared to 2022.
- [● 2 SOURCES] Investment in AI-driven oncology diagnostics and next-generation sequencing is driving growth in the cancer diagnostics market.
- [● 2 SOURCES] The cancer diagnostics market is projected to reach $44.69 billion by 2030, representing a CAGR of 11.8% from 2026.